OBJECTIVE: To determine whether pediatric PICU patients with mannose-binding lectin (MBL) gene polymorphisms associated with low levels of the functional protein have an increased risk of developing sepsis and SIRS. DESIGN AND SETTING: A prospective, observational cohort study in a 22-bed PICU in a tertiary referral centre. PATIENTS: One hundred consecutive admissions to a PICU with at least one organ system failure longer than 12 h. Patients were classified into those with infectious or non-infectious insults as the primary reason for intensive care admission. Patients were followed to determine which developed sepsis or non-infection related SIRS using standard criteria. MEASUREMENTS AND RESULTS: Of the 100 patients 50 had infectious and 50 had non-infectious insults as the precipitant for admission. 42 patients had variant MBL alleles (determined by MBL-2 gene exon 1 and promoter polymorphisms) and were significantly over-represented amongst the 59 patients that developed SIRS. This effect was not explained by differences in age, sex or ethnicity and was seen in both the infection and non-infection subgroups. In patients with infection, variant MBL alleles were associated with increased systemic response (2/15 with localised infection, 10/19 with sepsis and 12/16 with septic shock). MBL serum levels showed close concordance with the genotype and indicated that MBL levels less than 1000 ng/ml are associated with a greatly increased risk of SIRS. CONCLUSIONS: MBL-2 exon 1 polymorphisms with low serum levels of functional MBL protein are associated with a greatly increased risk of developing SIRS and of progression from infection to sepsis and septic shock in paediatric ICU patients.
OBJECTIVE: To determine whether pediatric PICU patients with mannose-binding lectin (MBL) gene polymorphisms associated with low levels of the functional protein have an increased risk of developing sepsis and SIRS. DESIGN AND SETTING: A prospective, observational cohort study in a 22-bed PICU in a tertiary referral centre. PATIENTS: One hundred consecutive admissions to a PICU with at least one organ system failure longer than 12 h. Patients were classified into those with infectious or non-infectious insults as the primary reason for intensive care admission. Patients were followed to determine which developed sepsis or non-infection related SIRS using standard criteria. MEASUREMENTS AND RESULTS: Of the 100 patients 50 had infectious and 50 had non-infectious insults as the precipitant for admission. 42 patients had variant MBL alleles (determined by MBL-2 gene exon 1 and promoter polymorphisms) and were significantly over-represented amongst the 59 patients that developed SIRS. This effect was not explained by differences in age, sex or ethnicity and was seen in both the infection and non-infection subgroups. In patients with infection, variant MBL alleles were associated with increased systemic response (2/15 with localised infection, 10/19 with sepsis and 12/16 with septic shock). MBL serum levels showed close concordance with the genotype and indicated that MBL levels less than 1000 ng/ml are associated with a greatly increased risk of SIRS. CONCLUSIONS:MBL-2 exon 1 polymorphisms with low serum levels of functional MBL protein are associated with a greatly increased risk of developing SIRS and of progression from infection to sepsis and septic shock in paediatric ICU patients.
Authors: A Koch; M Melbye; P Sørensen; P Homøe; H O Madsen; K Mølbak; C H Hansen; L H Andersen; G W Hahn; P Garred Journal: JAMA Date: 2001-03-14 Impact factor: 56.272
Authors: Peter Garred; Tacjana Pressler; Susanne Lanng; Hans O Madsen; Claus Moser; Inga Laursen; Flemming Balstrup; Claus Koch; Christian Koch Journal: Pediatr Pulmonol Date: 2002-03
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker; Benoit Vallet Journal: Intensive Care Med Date: 2005-02-18 Impact factor: 17.440
Authors: Melinda M Dean; Robert L Flower; Damon P Eisen; Robyn M Minchinton; Derek N J Hart; Slavica Vuckovic Journal: Immunology Date: 2010-11-23 Impact factor: 7.397
Authors: F N J Frakking; N Brouwer; N K A van Eijkelenburg; M P Merkus; T W Kuijpers; M Offringa; K M Dolman Journal: Clin Exp Immunol Date: 2007-08-17 Impact factor: 4.330
Authors: Adrian Plunkett; Rachel S Agbeko; Kawah Li; Steve E Humphries; Nigel J Klein; Mark J Peters Journal: Intensive Care Med Date: 2008-09-12 Impact factor: 17.440